JP2023544141A5 - - Google Patents
Info
- Publication number
- JP2023544141A5 JP2023544141A5 JP2023519464A JP2023519464A JP2023544141A5 JP 2023544141 A5 JP2023544141 A5 JP 2023544141A5 JP 2023519464 A JP2023519464 A JP 2023519464A JP 2023519464 A JP2023519464 A JP 2023519464A JP 2023544141 A5 JP2023544141 A5 JP 2023544141A5
- Authority
- JP
- Japan
- Prior art keywords
- aimp2
- composition according
- promoter
- gene
- mir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063085950P | 2020-09-30 | 2020-09-30 | |
| US63/085,950 | 2020-09-30 | ||
| PCT/IB2021/059017 WO2022070141A1 (en) | 2020-09-30 | 2021-09-30 | METHODS OF TREATING NEURONAL DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR miR-142 AND COMPOSITIONS THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544141A JP2023544141A (ja) | 2023-10-20 |
| JP2023544141A5 true JP2023544141A5 (https=) | 2025-03-06 |
Family
ID=80949780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519464A Pending JP2023544141A (ja) | 2020-09-30 | 2021-09-30 | ＡＩＭＰ２－ＤＸ２および必要に応じてｍｉＲ－１４２の標的配列ならびにその組成物を使用した神経系疾患を処置する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230374092A1 (https=) |
| EP (1) | EP4221759A4 (https=) |
| JP (1) | JP2023544141A (https=) |
| KR (1) | KR20230079267A (https=) |
| CN (1) | CN116507370A (https=) |
| AU (1) | AU2021354996A1 (https=) |
| CA (1) | CA3192710A1 (https=) |
| MA (1) | MA71714A (https=) |
| WO (1) | WO2022070141A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10716866B2 (en) | 2018-03-29 | 2020-07-21 | Generoath Co., Ltd | Pharmaceutical composition comprising AIMP2-DX2 for preventing or treating neuronal diseases and use thereof |
| KR102248420B1 (ko) * | 2019-03-15 | 2021-05-06 | 주식회사 제너로스 | miR-142-3p의 표적 서열을 포함하는 재조합 벡터 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459529B2 (en) * | 2004-11-24 | 2008-12-02 | Seoul National University Industry Foundation | AIMP2-DX2 and its uses |
| KR101067816B1 (ko) * | 2007-11-09 | 2011-09-27 | (주)네오믹스 | Ａｉｍｐ2-ｄｘ2의 억제제를 유효성분으로 포함하는 염증성질환 예방 및 치료용 조성물 |
| KR101749138B1 (ko) * | 2015-10-07 | 2017-06-20 | 원광대학교산학협력단 | 신경질환 예방 또는 치료를 위한 aimp2-dx2를 포함하는 약학 조성물 및 이의 용도 |
| US10716866B2 (en) * | 2018-03-29 | 2020-07-21 | Generoath Co., Ltd | Pharmaceutical composition comprising AIMP2-DX2 for preventing or treating neuronal diseases and use thereof |
| KR102349061B1 (ko) * | 2019-03-15 | 2022-01-10 | 주식회사 제너로스 | 생착능이 증가된 줄기세포의 제조 방법 |
| KR102248420B1 (ko) * | 2019-03-15 | 2021-05-06 | 주식회사 제너로스 | miR-142-3p의 표적 서열을 포함하는 재조합 벡터 |
-
2021
- 2021-09-30 US US18/246,575 patent/US20230374092A1/en active Pending
- 2021-09-30 EP EP21874707.9A patent/EP4221759A4/en active Pending
- 2021-09-30 AU AU2021354996A patent/AU2021354996A1/en not_active Abandoned
- 2021-09-30 JP JP2023519464A patent/JP2023544141A/ja active Pending
- 2021-09-30 KR KR1020237014841A patent/KR20230079267A/ko active Pending
- 2021-09-30 MA MA71714A patent/MA71714A/fr unknown
- 2021-09-30 WO PCT/IB2021/059017 patent/WO2022070141A1/en not_active Ceased
- 2021-09-30 CA CA3192710A patent/CA3192710A1/en active Pending
- 2021-09-30 CN CN202180066844.4A patent/CN116507370A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023544141A5 (https=) | ||
| JP2023544142A5 (https=) | ||
| JP2020203894A5 (https=) | ||
| JP7291423B2 (ja) | ＡＩＭＰ２－ＤＸ２およびｍｉＲ－１４２の標的核酸を含むベクター、ならびにその使用 | |
| JP2024023232A5 (https=) | ||
| EP0879288A1 (fr) | Variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique | |
| JP2021500016A5 (https=) | ||
| US20210260168A1 (en) | Compositions and methods of fas inhibition | |
| JP2019521692A5 (https=) | ||
| JP2022519196A5 (https=) | ||
| US11273170B2 (en) | Methods of treating cancer | |
| JP5933674B2 (ja) | 癌治療用の組合せ製品 | |
| JP2025501457A5 (https=) | ||
| JP2021534796A5 (https=) | ||
| JP2022543446A (ja) | Ａｐｏｅ４ ｒｎａ特異的トランススプライシングリボザイム及びその用途 | |
| JP2023506842A5 (https=) | ||
| JP2020517268A5 (https=) | ||
| JP2016518820A5 (https=) | ||
| JP2024524974A5 (https=) | ||
| US11052131B2 (en) | Methods and pharmaceutical compositions for the treatment of kidney cancer | |
| JP2024504467A5 (https=) | ||
| KR20200129959A (ko) | 무-운반체 다중 CRISPR/Cas 9 유전자 편집 복합체 및 그의 용도 | |
| AU2147901A (en) | Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy | |
| JP2024540002A5 (https=) | ||
| JP2020506695A5 (https=) |